PTPN11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.612200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.133800E-01
Normal-vs-Stage2
7.772800E-01
Normal-vs-Stage3
7.852400E-02
Normal-vs-Stage4
5.136400E-01
Stage1-vs-Stage2
2.937200E-01
Stage1-vs-Stage3
3.453600E-02
Stage1-vs-Stage4
8.889000E-01
Stage2-vs-Stage3
1.325360E-01
Stage2-vs-Stage4
3.150600E-01
Stage3-vs-Stage4
3.450100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.664200E-01
Normal-vs-AfricanAmerican
8.144600E-01
Normal-vs-Asian
2.998400E-01
Caucasian-vs-AfricanAmerican
5.147800E-01
Caucasian-vs-Asian
1.421960E-01
AfricanAmerican-vs-Asian
1.556180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.791200E-01
Normal-vs-Female
8.503600E-01
Male-vs-Female
9.587200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.560800E-01
Normal-vs-Age(41-60Yrs)
7.655400E-01
Normal-vs-Age(61-80Yrs)
7.258400E-01
Normal-vs-Age(81-100Yrs)
5.467000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.289200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.008800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.364000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.373700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.081390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.046800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.277800E-01
Normal-vs-Daily Drinker
3.006000E-01
Normal-vs-Weekly Drinker
8.294800E-01
Normal-vs-Occasional Drinker
8.679000E-01
Normal-vs-Social Drinker
7.881000E-01
Non Drinker-vs-Daily Drinker
7.933000E-01
Non Drinker-vs-Weekly Drinker
3.080000E-01
Non Drinker-vs-Occasional Drinker
4.946000E-02
Non Drinker-vs-Social Drinker
9.405600E-02
Daily Drinker-vs-Weekly Drinker
2.392600E-01
Daily Drinker-vs-Occasional Drinker
4.217900E-02
Daily Drinker-vs-Social Drinker
8.371900E-02
Weekly Drinker-vs-Occasional Drinker
5.192200E-01
Weekly Drinker-vs-Social Drinker
4.354600E-01
Occasional Drinker-vs-Social Drinker
7.675200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.083800E-01
Normal-vs-Grade 2
2.921800E-01
Normal-vs-Grade 3
2.449000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.847400E-01
Grade 1-vs-Grade 3
5.718200E-01
Grade 1-vs-Grade 4
4.083800E-01
Grade 2-vs-Grade 3
8.385400E-01
Grade 2-vs-Grade 4
2.921800E-01
Grade 3-vs-Grade 4
2.449000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.597000E-01
Normal-vs-NonDiabetic
7.695400E-01
Diabetic-vs-NonDiabetic
6.446200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.854200E-01
Normal-vs-NoPancreatitis
7.833600E-01
Pancreatitis-vs-NoPancreatitis
5.533800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.383000E-01
Normal-vs-N1
8.115600E-01
N0-vs-N1
7.155600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.458400E-01
Normal-vs-TP53-NonMutant
8.584000E-01
TP53-Mutant-vs-TP53-NonMutant
3.857400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
